Novartis Tasigna gets recommendation for EU approval
The Committee for Medicinal Products for Human Use (CHMP) recommended approval of Tasigna in the indication based on a pivotal Phase III clinical trial in which Tasigna surpassed
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
Erin Ascher will be responsible for leading Omnicare’s human resources function, including designing and implementing strategies in the areas of attracting, retaining, developing and rewarding employees. Before joining
Ozurdex, a biodegradable implant, delivers an extended release of the corticosteroid dexamethasone through intravitreal injection with Allergan’s proprietary Novadur solid polymer delivery system. Ozurdex’s efficacy for the treatment